About Expedeon
Expedeon is a company based in Swavesey (United Kingdom) founded in 2003 was acquired by Abcam in November 2019.. Expedeon has raised $390 thousand across 1 funding round from investors including Abcam, Santander Bank and SYGNIS. The company has 1,587 employees as of December 31, 2021. Expedeon offers products and services including Primary Antibodies, ELISA Kits, and Cell Lines. Expedeon operates in a competitive market with competitors including PrognomiQ, PreOmics, LenioBio, Vivostat and List Biological Laboratories, among others.
- Headquarter Swavesey, United Kingdom
- Employees 1587 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abcam Limited
- Date of Incorporation 12 Feb, 1998
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Expedeon
Expedeon offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, and Cell Lines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antibodies for detecting proteins in experiments and assays
Kits for measuring specific substances in samples
Gene-edited lines for research in genetics and diseases
Funding Insights of Expedeon
Expedeon has successfully raised a total of $390K through 1 strategic funding round. The most recent funding activity was a Seed round of $390 thousand completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $390,000
-
First Round
First Round
(22 Sep 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2014 | Amount | Seed - Expedeon | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Expedeon
Expedeon has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Abcam, Santander Bank and SYGNIS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Commercial banking services are offered in the United States.
|
Founded Year | Domain | Location | |
|
Biological reagents and antibodies are developed for life science research.
|
Founded Year | Domain | Location | |
|
SYGNIS provides molecular biology reagents for research and laboratory applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Expedeon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Expedeon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Expedeon Comparisons
Competitors of Expedeon
Expedeon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, PreOmics, LenioBio, Vivostat and List Biological Laboratories, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of tests for the detection and treatment of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
Reagents and instruments for proteomics research are supplied by PreOmics.
|
|
| domain | founded_year | HQ Location |
Kits for cell-free eukaryotic protein expression are provided.
|
|
| domain | founded_year | HQ Location |
On-site fibrin sealant preparation systems are developed and provided.
|
|
| domain | founded_year | HQ Location |
Specializes in the production of research reagents
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Expedeon
Frequently Asked Questions about Expedeon
When was Expedeon founded?
Expedeon was founded in 2003 and raised its 1st funding round 11 years after it was founded.
Where is Expedeon located?
Expedeon is headquartered in Swavesey, United Kingdom. It is registered at Swavesey, Cambridgeshire, United Kingdom.
Is Expedeon a funded company?
Expedeon is a funded company, having raised a total of $390K across 1 funding round to date. The company's 1st funding round was a Seed of $390K, raised on Sep 22, 2014.
How many employees does Expedeon have?
As of Dec 31, 2021, the latest employee count at Expedeon is 1,587.
What is the annual revenue of Expedeon?
Annual revenue of Expedeon is $636.76 as on Dec 31, 2021.
What does Expedeon do?
Expedeon was founded in 2003 in Swavesey, United Kingdom, and operates within the biotechnology sector focused on protein research. Solutions are provided for protein electrophoresis, proteomics, structural biology, protein purification, quantification, Western blotting, sample preparation, and cell signaling. Products such as gels, primers, stains, and antibodies are offered to support these applications in research settings.
Who are the top competitors of Expedeon?
What products or services does Expedeon offer?
Expedeon offers Primary Antibodies, ELISA Kits, and Cell Lines.
Who are Expedeon's investors?
Expedeon has 3 investors. Key investors include Abcam, Santander Bank, and SYGNIS.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.